semaglutide patent expiry date Ozempic's Protection Starts to Expire in 2026. What Next? What is the patent landscape

Korean Circulation Journal, 48(12),1097-1119

In BIR, inhibitory serine phosphorylation of IRS-1 (S312/S616/S636) disrupts PI3K/Akt signaling, deactivating downstream insulin signaling

Potential Side Effects and Adverse Reactions GLP-1 receptor agonists are powerful medications, and like all drugs, they come with a range of potential side effects

Among patients with PCOS, 55.7% of those prescribed a GLP-1 lost at least 10% of their body weight, compared to just 13.7% of those prescribed metformin

1961 obese, non-diabetic participants lost approximately 15% of their body weight over 68 weeks with once-weekly 2.4 mg injectable Semaglutide, alongside lifestyle changes